A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia
Authors
Keywords
-
Journal
PHARMACEUTICAL RESEARCH
Volume 39, Issue 6, Pages 1249-1265
Publisher
Springer Science and Business Media LLC
Online
2022-06-04
DOI
10.1007/s11095-022-03304-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A quantitative systems pharmacology model of hyporesponsiveness to erythropoietin in rats
- (2021) Ly Minh Nguyen et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)
- (2021) Jonathan Barratt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Single-Cell Tracking By Time Lapse Imaging Confirms Thrombopoietin Promotes Megakaryocytic-Erythroid Progenitor Self Renewal, but Does Not Instruct Lineage Commitment
- (2021) Vanessa M Scanlon et al. BLOOD
- Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review
- (2020) Simone Birocchi et al. PLATELETS
- Roxadustat: First Global Approval
- (2019) Sohita Dhillon DRUGS
- Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study
- (2019) Tadao Akizawa et al. THERAPEUTIC APHERESIS AND DIALYSIS
- How Can I Manage Thrombocytopenia in Hemodialysis Patient? A Review
- (2019) Qiaoyan Guo et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats
- (2018) Ly M. Nguyen et al. Frontiers in Pharmacology
- Thrombopoietin Metabolically Primes Hematopoietic Stem Cells to Megakaryocyte-Lineage Differentiation
- (2018) Ayako Nakamura-Ishizu et al. Cell Reports
- Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors
- (2017) Anna Mies et al. SEMINARS IN HEMATOLOGY
- TGF- inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors
- (2016) X. Gao et al. BLOOD
- The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia
- (2016) Harinder Gill et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Erythropoietin Receptor
- (2016) Stephanie S. Watowich JOURNAL OF INVESTIGATIVE MEDICINE
- PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal
- (2015) Hsiang-Ying Lee et al. NATURE
- Thrombopoietin Receptor Agonists: A Critical Review
- (2015) William B. Mitchell et al. SEMINARS IN HEMATOLOGY
- An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
- (2014) Soraya Carrancio et al. BRITISH JOURNAL OF HAEMATOLOGY
- High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias
- (2014) Joseph Y. Shin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate
- (2014) Amit Grover et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The biology of thrombopoietin and thrombopoietin receptor agonists
- (2013) David J. Kuter INTERNATIONAL JOURNAL OF HEMATOLOGY
- How important is transfusion avoidance in 2013?
- (2013) I. C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
- (2012) Matthew J. Olnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythropoietin-Induced Erythroid Precursor Pool Depletion Causes Erythropoietin Hyporesponsiveness
- (2012) Xiaoyu Yan et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim in Animals
- (2012) Wojciech Krzyzanski et al. PHARMACEUTICAL RESEARCH
- Thrombocytopenia associated with dialysis treatments
- (2011) Maria Aurora POSADAS et al. Hemodialysis International
- Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575
- (2011) Xiaoyu Yan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease
- (2011) Oluwatoyin F. Bamgbola KIDNEY INTERNATIONAL
- Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects
- (2010) Yow-Ming C. Wang et al. AAPS Journal
- HIF1 synergizes with glucocorticoids to promote BFU-E progenitor self-renewal
- (2010) J. Flygare et al. BLOOD
- From stem cell to erythroblast: Regulation of red cell production at multiple levels by multiple hormones
- (2010) Harvey Lodish et al. IUBMB LIFE
- Simultaneous Pharmacokinetics/Pharmacodynamics Modeling of Recombinant Human Erythropoietin upon Multiple Intravenous Dosing in Rats
- (2010) S. Ait-Oudhia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Biology and Chemistry of Thrombopoietic Agents
- (2010) David J. Kuter SEMINARS IN HEMATOLOGY
- Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody™ Construct CNTO 528 in Healthy Subjects
- (2009) Juan José Pérez-Ruixo et al. CLINICAL PHARMACOKINETICS
- Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review and Meta-analysis
- (2008) Benaya Rozen-Zvi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started